Expert on stem cell biology and regenerative medicine; developmental biology; ALS; Alzheimer’s disease; Frontotemporal Dementia; neurodegenerative diseases; induced pluripotent stem cells; cell reprogramming; disease modeling

Expert on stem cell biology and regenerative medicine; developmental biology; ALS; Alzheimer’s disease; Frontotemporal Dementia; neurodegenerative diseases; induced pluripotent stem cells; cell reprogramming; disease modeling
The findings suggest that further tightening of air quality standards could potentially reduce the risk of dementia in older populations. Contact: Leigh Hopper, (310) 308-0405 or lhopper@usc.edu. Older women who live in locations with high levels of air pollution may have more Alzheimer’s-like brain shrinkage than women who live in places with cleaner air, according […]
Having greater amounts of the peptide humanin is closely correlated with longer lives and better health in both animals and humans, including lower risk for Alzheimer’s. Contact: Jenesse Miller, (213) 810-8554 or jenessem@usc.edu or Orli Belman, (310) 709-4156 or obelman@usc.edu A new study led by researchers at the USC Leonard Davis School of Gerontology is […]
Researchers say the study is the first to investigate the association of different combinations of frequently used drugs and dementia risk in a large, representative sample of older Americans. Contact: Jenesse Miller, jenessem@usc.edu or 213-810-8554 Certain combinations of cardiovascular drugs may also reduce risk for Alzheimer’s disease, according to a new USC study of nearly […]
USC and Duke researchers say the framework illustrates how environmental and genetic factors interact. Against a backdrop of disappointing Alzheimer’s disease clinical trial outcomes, two researchers are proposing a new approach for future study of the disease. Caleb Finch of the USC Leonard Davis School of Gerontology and Alexander Kulminski of the Social Science Research […]
Expert in Alzheimer’s disease, Alzheimer’s disease in Down syndrome, clinical trials
Expert in dementia and assessing age-related cognitive changes
Expert in neuropsychiatry; Alzheimer’s, dementia and other neurodegenerative diseases and cognitive disorders
Expert in Alzheimer’s disease research and director of USC Alzheimer’s Therapeutic Research Institute